+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Manufacturing Execution System in Life Sciences Market Size, Share & Trends Analysis Report By Solution Type, By Deployment (On-Premise, Cloud/Web-Based, Hybrid), By End-User, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 5943878
Description Jump to:
The global manufacturing execution system in life sciences market size is anticipated to reach USD 6.0 billion by 2030, registering a CAGR of 12.2% from 2024 to 2030. The adoption of manufacturing execution system (MES) is emerging as a key factor in the life science industry, helping to improve efficiency, compliance, and innovation across production processes. In North America, MES implementation is experiencing a significant surge in the life science sector, highlighting its transformative impact on manufacturing workflows. Life science industries, including pharmaceuticals and biotechnology, require a sophisticated approach to manufacturing management. MES provides integrated and data-driven solutions that are instrumental in meeting and exceeding regulatory requirements, reducing risks, and ensuring product quality.

The growing demand for precision and quality in life science manufacturing is a key driver of market growth. MES enables companies to optimize production workflows, minimize errors, and maintain consistency in product development. Its flexibility and agility are especially valuable as the industry shifts toward personalized medicine and innovative therapies. Moreover, the prominence of Industry 4.0 technologies has bolstered the adoption of MES. Integration with the Internet of Things (IoT) and analytics creates an intelligent manufacturing ecosystem for life science manufacturers. This connectivity enables real-time monitoring, control, and data-driven decision-making, enhancing operational efficiency. Increasing demand for productivity, faster time-to-market, and superior product quality boost the adoption of MES in the life science industry. MES is becoming a central hub in the pursuit of a seamless, interconnected, and technologically advanced future in modern manufacturing.

Manufacturing Execution System in Life Sciences Market Report Highlights

  • The software solution type segment held the largest share in 2023 due to the high demand for paperless manufacturing, shift towards digitalization, and automation in manufacturing processes
  • The on-premise deployment segment held the largest share in 2023 and is expected to grow at a CAGR of 11.7% from 2024 to 2030. The on-premise MES system offers ease of storing data on premises and does not rely on heavy internet, which will not hamper communication
  • Such factors drive its adoption in the market. On the other hand, the cloud/web-based deployment segment is expected to grow at the fastest CAGR of 13.0% from 2024 to 2030
  • The pharmaceutical & biotechnology companies end-use segment held the largest share of 48.4% in 2023. This can be attributed to the high adoption of MES in this segment owing to the shifting trend towards automation and digitalization
  • North America dominated the global market with a share of 31.0% in 2023 owing to the presence of key players including Emerson Electric Co., Rockwell Automation, and Siemens AG. Asia Pacific is expected to grow at the fastest CAGR from 2024 to 2030
  • Various strategies, such as product development, partnerships, and mergers & acquisitions, are adopted by key players, which is driving the market competition
  • For instance, in September 2023, Körber and Endeavor partnered to facilitate the integration of Werum PAS-X MES with SAP's ERP platform. This partnership aims to provide a seamless solution for businesses that use these two software solutions for their operations

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Solution Type outlook
2.2.2. Deployment outlook
2.2.3. End-User outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Manufacturing Execution System in Life Sciences Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing demand for personalized medicine
3.2.1.2. Growth in pharmaceutical and biotechnology sector
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High implementation costs and complexity
3.3. Manufacturing Execution System in Life Sciences Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Manufacturing Execution System in Life Sciences Market: Solution Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Segment Dashboard
4.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
4.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analysis, by Solution Type, 2018 to 2030 (USD Million)
4.4.1. Software
4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Services
4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Manufacturing Execution System in Life Sciences Market: Deployment Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Segment Dashboard
5.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
5.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analyses, by Deployment, 2018 to 2030 (USD Million)
5.4.1. On-Premise
5.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Cloud/Web-based
5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Hybrid
5.4.3.1. Hybrid market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Manufacturing Execution System in Life Sciences Market: End-user Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Segment Dashboard
6.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
6.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analyses, by End-User, 2018 to 2030 (USD Million)
6.4.1. Pharmaceutical and Biotechnology Companies
6.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.2. Medical Device Companies
6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.4.3. Others (CDMOs, CROs, etc.)
6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Manufacturing Execution System in Life Sciences Market: Regional Estimates & Trend Analysis by Solution Type, Deployment, & End-User
7.1. Regional Market Dashboard
7.2. Global Regional Market Snapshot
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.4. North America
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. U.S. country dynamics
7.4.2.2. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Canada country dynamics
7.4.3.2. Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. UK country dynamics
7.5.2.2. UK market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Germany country dynamics
7.5.3.2. Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. France country dynamics
7.5.4.2. France market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Italy country dynamics
7.5.5.2. Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Spain country dynamics
7.5.6.2. Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Norway country dynamics
7.5.7.2. Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Sweden
7.5.8.2. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.5.9. Denmark
7.5.9.1. Denmark
7.5.9.2. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Japan country dynamics
7.6.2.2. Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. China country dynamics
7.6.3.2. China market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. India country dynamics
7.6.4.2. India market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Australia country dynamics
7.6.5.2. Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. South Korea
7.6.6.2. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Thailand
7.6.7.2. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Brazil
7.7.2.2. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. Mexico
7.7.3.1. Mexico
7.7.3.2. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.7.4. Argentina
7.7.4.1. Argentina country dynamics
7.7.4.2. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. South Africa country dynamics
7.8.2.2. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Saudi Arabia country dynamics
7.8.3.2. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. UAE country dynamics
7.8.4.2. UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Kuwait country dynamics
7.8.5.2. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. ABB
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Körber AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. MasterControl Solutions, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. AVEVA Group Limited
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Cognizant
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Rockwell Automation
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. nagarro
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Siemens AG
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Emerson Electric Co.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. iBase-t
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America MES in life sciences market, by region, 2018 - 2030 (USD Million)
Table 3 North America MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 4 North America MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 5 North America MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 6 U.S. MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 7 U.S. MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 8 U.S. MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 9 Canada MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 10 Canada MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 11 Canada MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 12 Europe MES in life sciences market, by region, 2018 - 2030 (USD Million)
Table 13 Europe MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 14 Europe MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 15 Europe MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 16 Germany MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 17 Germany MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 18 Germany MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 19 UK MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 20 UK MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 21 UK MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 22 France MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 23 France MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 24 France MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 25 Italy MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 26 Italy MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 27 Italy MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 28 Spain MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 29 Spain MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 30 Spain MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 31 Denmark MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 32 Denmark MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 33 Denmark MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 34 Sweden MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 35 Sweden MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 36 Sweden MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 37 Norway MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 38 Norway MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 39 Norway MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 40 Asia Pacific MES in life sciences market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 43 Asia Pacific MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 44 China MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 45 China MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 46 China MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 47 Japan MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 48 Japan MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 49 Japan MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 50 India MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 51 India MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 52 India MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 53 South Korea MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 54 South Korea MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 55 South Korea MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 56 Australia MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 57 Australia MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 58 Australia MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 59 Thailand MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 60 Thailand MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 61 Thailand MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 62 Latin America MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 63 Latin America MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 64 Latin America MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 65 Brazil MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 66 Brazil MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 67 Brazil MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 68 Mexico MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 69 Mexico MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 70 Mexico MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 71 Argentina MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 72 Argentina MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 73 Argentina surgical ablation market, by end-user, 2018 - 2030 (USD Million)
Table 74 MEA MES in life sciences market, by region, 2018 - 2030 (USD Million)
Table 75 MEA MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 76 MEA MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 77 MEA MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 78 South Africa MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 79 South Africa MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 80 South Africa MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 84 UAE MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 85 UAE MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 86 UAE MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 87 Kuwait MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
Table 88 Kuwait MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
Table 89 Kuwait MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
Table 90 List of other players
Table 91 Participant’s overview
Table 92 Financial per Deploymentance
Table 93 Key companies undergoing expansions
Table 94 Key companies undergoing acquisitions
Table 95 Key companies undergoing collaborations
Table 96 Key companies launching new components/services
Table 97 Key companies undergoing partnerships
Table 98 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 MES in life sciences market: market outlook
Fig. 10 MES in life sciences competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 MES in life sciences market driver impact
Fig. 16 MES in life sciences market restraint impact
Fig. 17 MES in life sciences market strategic initiatives analysis
Fig. 18 MES in life sciences market: Solution Type movement analysis
Fig. 19 MES in life sciences market: Solution Type outlook and key takeaways
Fig. 20 Software market estimates and forecast, 2018 - 2030
Fig. 21 Services estimates and forecast, 2018 - 2030
Fig. 22 MES in life sciences market: deployment movement analysis
Fig. 23 MES in life sciences market: deployment outlook and key takeaways
Fig. 24 On-premise market estimates and forecast, 2018 - 2030
Fig. 25 Clou/Web-based market estimates and forecast,2018 - 2030
Fig. 26 Hybrid market estimates and forecast,2018 - 2030
Fig. 27 MES in life sciences market: end-user movement analysis
Fig. 28 MES in life sciences market: end-user outlook and key takeaways
Fig. 29 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030
Fig. 30 Medical Device Companies market estimates and forecast,2018 - 2030
Fig. 31 Others market estimates and forecast, 2018 - 2030
Fig. 32 Global MES in life sciences market: regional movement analysis
Fig. 33 Global MES in life sciences market: regional outlook and key takeaways
Fig. 34 Global MES in life sciences market share and leading players
Fig. 35 North America market share and leading players
Fig. 36 Europe market share and leading players
Fig. 37 Asia Pacific market share and leading players
Fig. 38 Latin America market share and leading players
Fig. 39 Middle East & Africa market share and leading players
Fig. 40 North America: SWOT
Fig. 41 Europe SWOT
Fig. 42 Asia Pacific SWOT
Fig. 43 Latin America SWOT
Fig. 44 MEA SWOT
Fig. 45 North America, by country
Fig. 46 North America market estimates and forecast, 2018 - 2030
Fig. 47 U.S. market estimates and forecast, 2018 - 2030
Fig. 48 Canada market estimates and forecast, 2018 - 2030
Fig. 49 Europe market estimates and forecast, 2018 - 2030
Fig. 50 UK market estimates and forecast, 2018 - 2030
Fig. 51 Germany market estimates and forecast, 2018 - 2030
Fig. 52 France market estimates and forecast, 2018 - 2030
Fig. 53 Italy market estimates and forecast, 2018 - 2030
Fig. 54 Spain market estimates and forecast, 2018 - 2030
Fig. 55 Denmark market estimates and forecast, 2018 - 2030
Fig. 56 Sweden market estimates and forecast, 2018 - 2030
Fig. 57 Norway market estimates and forecast, 2018 - 2030
Fig. 58 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 59 China market estimates and forecast, 2018 - 2030
Fig. 60 Japan market estimates and forecast, 2018 - 2030
Fig. 61 India market estimates and forecast, 2018 - 2030
Fig. 62 Thailand market estimates and forecast, 2018 - 2030
Fig. 63 South Korea market estimates and forecast, 2018 - 2030
Fig. 64 Australia market estimates and forecast, 2018 - 2030
Fig. 65 Latin America market estimates and forecast, 2018 - 2030
Fig. 66 Brazil market estimates and forecast, 2018 - 2030
Fig. 67 Mexico market estimates and forecast, 2018 - 2030
Fig. 68 Argentina market estimates and forecast, 2018 - 2030
Fig. 69 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 70 South Africa market estimates and forecast, 2018 - 2030
Fig. 71 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 72 UAE market estimates and forecast, 2018 - 2030
Fig. 73 Kuwait market estimates and forecast, 2018 - 2030
Fig. 74 Market share of key market players - MES in life sciences market

Companies Mentioned

  • ABB
  • Körber AG
  • MasterControl Solutions, Inc.
  • AVEVA Group Limited
  • Cognizant
  • Rockwell Automation
  • nagarro
  • Siemens AG
  • Emerson Electric Co.
  • iBase-t

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedFebruary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 6 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Manufacturing Execution System Market by Offerings, Function, Industry, Deployment - Global Forecast 2025-2030 - Product Image

Manufacturing Execution System Market by Offerings, Function, Industry, Deployment - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Manufacturing Execution Systems Market by Offering (Software, Services), Deployment (On-premises, On-demand, Hybrid), Process Industry (Oil & Gas, Pharmaceuticals & Life Sciences), Discrete Industry (Automotive, Aerospace) - Forecast to 2029 - Product Image

Manufacturing Execution Systems Market by Offering (Software, Services), Deployment (On-premises, On-demand, Hybrid), Process Industry (Oil & Gas, Pharmaceuticals & Life Sciences), Discrete Industry (Automotive, Aerospace) - Forecast to 2029

  • Report
  • 234 Pages
  • Global
From
Manufacturing Execution System In Life Sciences Market Analysis & Forecast to 2024-2034 - Product Image

Manufacturing Execution System In Life Sciences Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Manufacturing Execution System Global Market Report 2024 - Product Image

Manufacturing Execution System Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Manufacturing Execution Systems (MES) - Global Strategic Business Report - Product Image

Manufacturing Execution Systems (MES) - Global Strategic Business Report

  • Report
  • 810 Pages
  • Global
From

About the Life Sciences Manufacturing Execution System Market

Within the field of biotechnology, the Life Sciences Manufacturing Execution System (MES) market comprises the specialized software and system solutions tailored for managing and monitoring the production processes of pharmaceuticals, biologics, and medical devices. MES is crucial in ensuring compliance with strict regulatory standards and Good Manufacturing Practices (GMP). These systems provide real-time data tracking and analysis, facilitating efficient process control, and quality assurance across various stages of production, from raw material handling to the final product. Life Sciences MES assists biotech companies in addressing complex manufacturing challenges, such as batch processing, traceability, and validation, while enhancing operational efficiency. It integrates with other information systems (such as Enterprise Resource Planning (ERP) and Laboratory Information Management Systems (LIMS)), ensuring data consistency and streamlining workflows. By minimizing paperwork and manual operations, MES reduces the likelihood of human error, leading to improved product quality and consistency. Prominent companies within the Life Sciences MES market include Siemens AG, which provides the SIMATIC IT eBR software for electronic batch recording; Honeywell International with its Honeywell PAS X MES solution; Emerson Electric Co., offering the Syncade MES suite; and Rockwell Automation, known for its PharmaSuite MES. Other key players include Werum IT Solutions GmbH, part of the Körber Group, delivering MES software tailored to the unique requirements of the life science industry, and GE Healthcare's Digital plant solution. These companies play a pivotal role in propelling the efficiency and compliance of biotechnology manufacturing processes. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.